Predictors of Adherence to Highly Active Antiretroviral Therapy among People Living with HIV/AIDS in Akwa Ibom State, Nigeria

Adherence to Highly Active Antiretroviral Therapy (HAART) remains critical for achieving viral suppression and reducing HIV-related morbidity and mortality, particularly in high-burden settings such as Akwa Ibom State, Nigeria. This study assessed the level of HAART adherence and its associated predictors among People Living with HIV (PLHIV) receiving antiretroviral therapy in Akwa Ibom State.
A descriptive cross-sectional study design was employed among 200 PLHIV accessing HIV care services in selected ART-supported health facilities across Akwa Ibom State. Data were collected using a structured, interviewer-administered questionnaire. HAART adherence was assessed using a four-day recall method. Descriptive statistics were used to summarize respondents’ characteristics, while chi-square tests were conducted to determine associations between HAART adherence and selected patient-related, socio-cultural, and health-system factors at a significance level of p < 0.05.
The study found that 79.5% of respondents were adherent to HAART, a level below the World Health Organization recommended threshold of ≥95%. HIV status disclosure (χ² = 9.21; p = 0.002), family support (χ² = 6.74; p = 0.009), and use of medication reminders (χ² = 18.63; p < 0.001) were significantly associated with better adherence. Conversely, fear of stigma (χ² = 11.84; p = 0.001) and long clinic waiting times (χ² = 13.02; p < 0.001) were significantly associated with non-adherence. Forgetfulness, treatment fatigue, and health-system barriers were identified as major challenges to optimal adherence.
In conclusion, HAART adherence among PLHIV in Akwa Ibom State is moderately high but remains suboptimal. Adherence is influenced by an interplay of patient-related, socio-cultural, and health-system factors. Strengthening adherence counselling, promoting safe disclosure, integrating family and digital reminder support, reducing clinic waiting times, and intensifying anti-stigma interventions are essential for improving treatment outcomes and achieving sustained viral suppression in Akwa Ibom State.

HAART adherence, HIV, predictors, stigma, Akwa Ibom State, Nigeria

1. 2018, N. R. (2018). NIGERIA HIV/AIDS INDICATOR AND IMPACT SURVEY PARTNERS. https://www.naiis.ng/resource/NAIIS-Report-2018.pdf [Google Scholar] [Crossref]

2. Abadiga, M., Hasen, T., Mosisa, G., & Abdisa, E. (2020a). Adherence to antiretroviral therapy and associated factors among Human immunodeficiency virus positive patients accessing treatment at Nekemte referral hospital, west Ethiopia, 2019. PLOS ONE, 15(5), e0232703. [Google Scholar] [Crossref]

3. https://doi.org/10.1371/journal.pone.0232703 [Google Scholar] [Crossref]

4. Abadiga, M., Hasen, T., Mosisa, G., & Abdisa, E. (2020b). Adherence to antiretroviral therapy and associated factors among Human immunodeficiency virus positive patients accessing treatment at Nekemte referral hospital, west Ethiopia, 2019. PLOS ONE, 15(5), e0232703. [Google Scholar] [Crossref]

5. https://doi.org/10.1371/journal.pone.0232703 [Google Scholar] [Crossref]

6. Akpan, U., Kakanfo, K., Ekele, O. D., Ukpong, K., Toyo, O., Nwaokoro, P., James, E., Pandey, S., Olatubosun, K., & Bateganya, M. (2022). Predictors of treatment interruption among patients on antiretroviral therapy in Akwa Ibom, Nigeria: outcomes after 12 months. AIDS Care, 1–9. https://doi.org/10.1080/09540121.2022.2093826 [Google Scholar] [Crossref]

7. Archibong Edem Bassey, & Goshen David Miteu. (2023). A review of current trends in hiv epidemiology, surveillance and control in Nigeria. Annals of Medicine and Surgery, Publish Ahead of Print (5). https://doi.org/10.1097/ms9.0000000000000604 [Google Scholar] [Crossref]

8. ART adherence in resource poor settings in sub-Saharan Africa: a multi- disciplinary review Author: Eliud Wekesa. (n.d.). Retrieved September 22, 2024, from [Google Scholar] [Crossref]

9. https://repository.seku.ac.ke/bitstream/handle/123456789/3210/Wekesa_ART%20adherence%20in%20resource%20poor%20settings%20in%20sub-Saharan%20Africa.pdf?sequence=1 [Google Scholar] [Crossref]

10. Banagi, Y., Yathiraj, B., & Ramesh, S. (2016). Factors influencing adherence to antiretroviral therapy among people living with HIV. International Journal of Community Medicine and Public Health, 3(7), 1733–1738. [Google Scholar] [Crossref]

11. Bukenya, D., Mayanja, B. N., Nakamanya, S., Muhumuza, R., & Seeley, J. (2019). What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda. AIDS Research and Therapy, 16(1). https://doi.org/10.1186/s12981-018-0214-y [Google Scholar] [Crossref]

12. Centers for Disease Control (CDC). (1981). Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. MMWR. Morbidity and Mortality Weekly Report, 30(25), 305–308. https://pubmed.ncbi.nlm.nih.gov/6789108/ [Google Scholar] [Crossref]

13. Cheng, Y., Sauer, B., Zhang, Y., Nickman, N. A., Jamjian, C., Stevens, V., & LaFleur, J. (2018). Adherence and virologic outcomes among treatment-naïve veteran patients with human immunodeficiency virus type 1 infection. Medicine, 97(2), e9430. [Google Scholar] [Crossref]

14. https://doi.org/10.1097/md.0000000000009430 [Google Scholar] [Crossref]

15. Chesney, M. A. (2000). Factors Affecting Adherence to Antiretroviral Therapy. Clinical Infectious Diseases, 30(Supplement_2), S171–S176. https://doi.org/10.1086/313849 [Google Scholar] [Crossref]

16. Cihlar, T., & Fordyce, M. (2016). Current status and prospects of HIV treatment. Current Opinion in Virology, 18, 50–56. https://doi.org/10.1016/j.coviro.2016.03.004 [Google Scholar] [Crossref]

17. Desta;, A. (2020). Health related quality of life of people receiving highly active antiretroviral therapy in Southwest Ethiopia. PLOS ONE, 15(8), 1–14. https://ideas.repec.org/a/plo/pone00/0237013.html [Google Scholar] [Crossref]

18. Edet, J. (2024). Volume 12 Issue 10 October 2024. Igmpublication.org. [Google Scholar] [Crossref]

19. https://jmscr.igmpublication.org/home/index.php/archive/229-volume-12-issue-10-october-2024 [Google Scholar] [Crossref]

20. Federal Ministry of Health. (2019). Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) [Google Scholar] [Crossref]

21. Heestermans,. (2016). Heestermans, T., Browne, J.L., Aitken, S.C., et al. (2016) Determinants of Adherence to Antiretroviral Therapy among HIV-Positive Adults in Sub-Saharan Africa A Systematic Review. BMJ Global Health, 1, e000125. - References - Scientific Research Publishing. Scirp.org. https://www.scirp.org/reference/referencespapers?referenceid=2584523 [Google Scholar] [Crossref]

22. Heestermans, T., Browne, J. L., Aitken, S. C., Vervoort, S. C., & Klipstein-Grobusch, K. (2016). Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ Global Health, 1(4), e000125. https://doi.org/10.1136/bmjgh-2016-000125 [Google Scholar] [Crossref]

23. HIV.gov. (2022, August 3). The global HIV/AIDS epidemic. HIV.gov. https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics [Google Scholar] [Crossref]

24. HIV/AID-protection and early detection, promise of health. (2021). WHO | Regional Office for Africa. https://www.afro.who.int/news/hivaid-protection-and-early-detection-promise-health#:~:text=Nigeria%20has%20the%20second%2Dlargest [Google Scholar] [Crossref]

25. Kanu, C. T., Maduka, O., & Okeafor, C. U. (2017). Perceived stigma and highly active antiretroviral treatment adherence among persons living with HIV/AIDS in the University of Port Harcourt Teaching Hospital. Orient Journal of Medicine, 29(1-2), 40–47. [Google Scholar] [Crossref]

26. https://www.ajol.info/index.php/ojm/article/view/154682 [Google Scholar] [Crossref]

27. National Agency for the Control of AIDS (NACA). (2020). Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) 2018: Technical report. Abuja: NACA. [Google Scholar] [Crossref]

28. National Library of Medicine. (2024). National center for biotechnology information. Nih.gov; National Library of Medicine. https://www.ncbi.nlm.nih.gov/ [Google Scholar] [Crossref]

29. Nieuwkerk, P. T., & Oort, F. J. (2005). Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response. Journal of Acquired Immune Deficiency Syndromes, 38(4), 445–448. [Google Scholar] [Crossref]

30. O’BRIEN-CARELLI, C., STEUBEN, K., STAFFORD, K. A., ALIOGO, R., ALAGI, M., JOHANNS, C. K., IBRAHIM, J., SHIRAISHI, R., EHOCHE, A., GREBY, S., DIRLIKOV, E., IBRAHIM, D., BRONSON, M., ALIYU, G., ALIYU, S., DWYER-LINDGREN, L., SWAMINATHAN, M., DUBER, H. C., & CHARURAT, M. (2022). Mapping HIV prevalence in Nigeria using small area estimates to develop a targeted HIV intervention strategy. PLOS ONE, 17(6), e0268892. [Google Scholar] [Crossref]

31. https://doi.org/10.1371/journal.pone.0268892 [Google Scholar] [Crossref]

32. Onwunata, A. A., et al. (2019). Determinants of adherence to antiretroviral therapy among people living with HIV in Nigeria. Journal of Public Health in Africa, 10(1), 101–108. [Google Scholar] [Crossref]

33. Richard, U., Eneojo. (2018). Assessment of Antiretroviral Therapy Outcomes among Key Populations after 6 Months of Initiation in Nigeria. TEXILA INTERNATIONAL JOURNAL of PUBLIC HEALTH, 6(2), 164–176. https://doi.org/10.21522/tijph.2013.06.02.art019 [Google Scholar] [Crossref]

34. Sharp, P. M., & Hahn, B. H. (2010). The evolution of HIV-1 and the origin of AIDS. Philosophical Transactions of the Royal Society B: Biological Sciences, 365(1552), 2487–2494. https://doi.org/10.1098/rstb.2010.0031 [Google Scholar] [Crossref]

35. Sharp, P. M., & Hahn, B. H. (2011). Origins of HIV and the AIDS Pandemic. Cold Spring Harbor Perspectives in Medicine, 1(1). https://doi.org/10.1101/cshperspect.a006841 [Google Scholar] [Crossref]

36. Tigabu Munye Aytenew, Demis, S., Binyam Minuye Birhane, Worku Necho Asferie, Amare Simegn, Gedefaye Nibret, Amare Kassaw, Sintayehu Asnakew, Yohannes Tesfahun, Henock Andualem, Berihun Bantie, Gebrie Kassaw, Demewoz Kefale, & Zeleke, S. (2023). Non-Adherence to Anti-Retroviral Therapy Among Adult People Living with HIV in Ethiopia: Systematic Review and Meta-Analysis. AIDS and Behavior. https://doi.org/10.1007/s10461-023-04252-4 [Google Scholar] [Crossref]

37. Tian, Y., et al. (2023). Global trends in HIV incidence and mortality. The Lancet Global Health, 11(9), e1345–e1356. [Google Scholar] [Crossref]

38. Ugwu, R., & Eneh, A. (2013). Factors influencing adherence to paediatric antiretroviral therapy in Portharcourt, South- South Nigeria. Pan African Medical Journal, 16. [Google Scholar] [Crossref]

39. https://doi.org/10.11604/pamj.2013.16.30.1877 [Google Scholar] [Crossref]

40. UNAIDS. (2022). UNAIDS Data 2022. Geneva: UNAIDS. [Google Scholar] [Crossref]

41. UNAIDS. (2023). 2022 GLOBAL HIV STATISTICS. In UNAIDS. [Google Scholar] [Crossref]

42. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf [Google Scholar] [Crossref]

43. UNAIDS. (2024). Global HIV & AIDS Statistics — 2024 Fact Sheet. UNAIDS; UNAIDS. [Google Scholar] [Crossref]

44. https://www.unaids.org/en/resources/fact-sheet [Google Scholar] [Crossref]

45. WHO. (2020). WHO | Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. WHO. https://www.who.int/hiv/pub/guidelines/keypopulations/en/ [Google Scholar] [Crossref]

46. World Health Organization. (2018). HIV/AIDS. WHO | Regional Office for Africa. https://www.afro.who.int/health-topics/hivaids [Google Scholar] [Crossref]

47. World Health Organization. (2021, July 16). Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Www.who.int. https://www.who.int/publications/i/item/9789240031593 [Google Scholar] [Crossref]

48. World Health Organization. (2024, July 22). HIV and AIDS. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/hiv-aids [Google Scholar] [Crossref]

49. Wikipedia. (2021). Akwa Ibom State. [Google Scholar] [Crossref]

• Tribal Child Nutrition and Health in District of Sundargarh: A Public Health Review of ICDS Intervention
• Knowledge, Attitudes and Practices Towards Prostate Cancer Screening Amongst Men Aged 40-60 Years in The Buea Health District: A Cross-Sectional Study
• Compliance with JCI Protocols: A Focus on Employee Safety
• Influence and Involvement of Teachers in Menstrual Hygiene Management of Female Secondary School Students in Kogi State, Nigeria
• A Critical Evaluation of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana in Bihar